Dicot Pharma AB (STO:DICOT)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.2940
+0.0110 (3.89%)
At close: May 5, 2026
Market Cap590.75M +6.3%
Revenue (ttm)n/a
Net Income-72.14M
EPSn/a
Shares Out2.01B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume10,623,390
Average Volume9,461,102
Open0.2806
Previous Close0.2830
Day's Range0.2654 - 0.3000
52-Week Range0.2418 - 1.1800
Beta0.91
RSI31.63
Earnings DateApr 30, 2026

About Dicot Pharma AB

Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It develops LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden. [Read more]

Sector Healthcare
Founded 2015
Employees 4
Stock Exchange Nasdaq Stockholm
Ticker Symbol DICOT
Full Company Profile

Financial Performance

Financial Statements